As a healthcare company, the Daiichi Sankyo Group is involved in various initiatives that contribute to progress in medicine and pharmacology, supporting people’s every day healthy lives.
Support for Healthcare and Life Science Institutions
The Group Group makes donations to following two public interest incorporated foundations in order to contribute to the development of medicine and pharmacology:
Daiichi Sankyo Foundation of Life Science
The Daiichi Sankyo Foundation of Life Science seeks to support unique research in the life science field by providing grants for research, overseas study programs, and other purposes and presenting awards (Takamine Memorial Daiichi Sankyo Prize, etc.).
Click here for more information.
Japan Research Foundation for Clinical Pharmacology
The Japan Research Foundation for Clinical Pharmacology provides funding to clinical pharmacology research (including research and overseas study programs) with the aim of contributing to the advancement of clinical pharmacology and the development of researchers in this field. In addition, the foundation, in collaboration with the Japanese Society of Clinical Pharmacology and Therapeutic, presents the Japan Research Foundation for Clinical Pharmacology Award and hosts intensive clinical pharmacology courses.
Click here for more information.
Moreover, the Manpei Suzuki Diabetes Foundation, a shareholder of Daiichi Sankyo Co., Ltd., provides grants for overseas study and research programs, as well as confers awards, with the aim of advancing diabetes research
Click here for more information.
"Habataku": Soring Next- Generation Researcher Development Program - Empowering Future Basic Researchers
Basic research is a source of innovation that drives social and economic change. To advance basic research in Japan, we provide funding to research programs and next-generation researchers, enabling them to expand their global presence through research management organizations at universities and other institutions.
Click here for more information. (Available only in Japanese)
Scholarships and Fellowships to Fudan University in Shanghai
Daiichi Sankyo (China) Holdings Co., Ltd. provides scholarships and fellowships to medical and pharmaceutical doctoral and master’s degree students, as well as faculty members at Fudan University in Shanghai, to support their research through the Daiichi Sankyo Pharmaceutical Oriental Scholarship Program at Fudan University.
Awards Ceremony in 2024
Scholarship Programs in Collaboration with the International Health Exchange and Cooperation Center of the National Health Commission
Daiichi Sankyo (China) Holdings Co., Ltd. established and has been operating a scholarship program since 1995 to cultivate and support medical professionals by providing scholarship to outstanding medical students.
Awards ceremony held in 2023
Support for the Florence Nightingale Medal Program
The Florence Nightingale Medal is the highest honor awarded biennially by the International Committee of the Red Cross to nurses who have made outstanding contributions to the nursing profession. In 2025, 35 nurses from 17 countries and regions received the award, including three from Japan. Daiichi Sankyo supports this award through donations to the ceremony organized by the Japanese Red Cross Society.
Support for health awareness activities in Shanghai
Since fiscal year 2014, Daiichi Sankyo (China) Holdings Co., Ltd. has been supporting programs carried out by resident physicians from hospitals in the Shanghai region to raise public awareness of health-related information, Currently, 27 hospitals have conduct various online and on-site activities on a monthly basis. Employees of Daiichi Sankyo (China) also have been participating as volunteers.
Daiichi Sankyo (China) Social Contribution Activities Report
Activities